Orally administered proteases in aesthetic surgery.
Identifieur interne : 012A98 ( Main/Exploration ); précédent : 012A97; suivant : 012A99Orally administered proteases in aesthetic surgery.
Auteurs : M. Dusková [République tchèque] ; M. WaldSource :
- Aesthetic plastic surgery [ 0364-216X ]
Descripteurs français
- KwdFr :
- Administration par voie orale, Adulte, Adulte d'âge moyen, Aescine (administration et posologie), Association médicamenteuse, Blépharoplastie, Complications postopératoires (), Humains, Hydrolases (administration et posologie), Hémostatiques (administration et posologie), Rutoside (administration et posologie), Soins postopératoires, Sujet âgé, Étamsylate (administration et posologie), Études prospectives.
- MESH :
- administration et posologie : Aescine, Hydrolases, Hémostatiques, Rutoside, Étamsylate.
- Administration par voie orale, Adulte, Adulte d'âge moyen, Association médicamenteuse, Blépharoplastie, Complications postopératoires, Humains, Soins postopératoires, Sujet âgé, Études prospectives.
English descriptors
- KwdEn :
- Administration, Oral, Adult, Aged, Blepharoplasty, Drug Combinations, Escin (administration & dosage), Ethamsylate (administration & dosage), Hemostatics (administration & dosage), Humans, Hydrolases (administration & dosage), Middle Aged, Postoperative Care, Postoperative Complications (prevention & control), Prospective Studies, Rutin (administration & dosage).
- MESH :
- chemical , administration & dosage : Escin, Ethamsylate, Hemostatics, Hydrolases, Rutin.
- chemical : Drug Combinations.
- prevention & control : Postoperative Complications.
- Administration, Oral, Adult, Aged, Blepharoplasty, Humans, Middle Aged, Postoperative Care, Prospective Studies.
Abstract
Increasing demand for shortening the sequel period after aesthetic surgery has led to comparative testing of optional approaches. Systemic enzyme therapy with its pharmacological effects represents a preventive and curative option for inflammatory process including healing. Excellent results were presented, namely, in the treatment of secondary lymphoedema. The incidence of hematoma, edema, and pain was followed, and the results were compared in a randomized group of 20 patients with upper eyelid blepharoplasty treated with proteases (Wobenzym drg) and in a similar group treated with systemic antiedema and hemostyptic therapy (Dicynone drg and Reparil drg). No undesirable side effects were observed. In addition, proteases apparently have no limitation for patients with the risk of concurrent cardiovascular, hepatic, or renal diseases.
PubMed: 10022937
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004D20
- to stream PubMed, to step Curation: 004D20
- to stream PubMed, to step Checkpoint: 004D20
- to stream Ncbi, to step Merge: 000004
- to stream Ncbi, to step Curation: 000004
- to stream Ncbi, to step Checkpoint: 000004
- to stream Main, to step Merge: 013D14
- to stream Main, to step Curation: 012A98
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Orally administered proteases in aesthetic surgery.</title>
<author><name sortKey="Duskova, M" sort="Duskova, M" uniqKey="Duskova M" first="M" last="Dusková">M. Dusková</name>
<affiliation wicri:level="3"><nlm:affiliation>Klinika plastické chirurgie, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Klinika plastické chirurgie, Prague</wicri:regionArea>
<placeName><settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wald, M" sort="Wald, M" uniqKey="Wald M" first="M" last="Wald">M. Wald</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>1999 Jan-Feb</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:10022937</idno>
<idno type="pmid">10022937</idno>
<idno type="wicri:Area/PubMed/Corpus">004D20</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004D20</idno>
<idno type="wicri:Area/PubMed/Curation">004D20</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004D20</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004D20</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004D20</idno>
<idno type="wicri:Area/Ncbi/Merge">000004</idno>
<idno type="wicri:Area/Ncbi/Curation">000004</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000004</idno>
<idno type="wicri:doubleKey">0364-216X::Duskova M:orally:administered:proteases</idno>
<idno type="wicri:Area/Main/Merge">013D14</idno>
<idno type="wicri:Area/Main/Curation">012A98</idno>
<idno type="wicri:Area/Main/Exploration">012A98</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Orally administered proteases in aesthetic surgery.</title>
<author><name sortKey="Duskova, M" sort="Duskova, M" uniqKey="Duskova M" first="M" last="Dusková">M. Dusková</name>
<affiliation wicri:level="3"><nlm:affiliation>Klinika plastické chirurgie, Prague, Czech Republic.</nlm:affiliation>
<country xml:lang="fr">République tchèque</country>
<wicri:regionArea>Klinika plastické chirurgie, Prague</wicri:regionArea>
<placeName><settlement type="city">Prague</settlement>
<region type="région" nuts="2">Bohême centrale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wald, M" sort="Wald, M" uniqKey="Wald M" first="M" last="Wald">M. Wald</name>
</author>
</analytic>
<series><title level="j">Aesthetic plastic surgery</title>
<idno type="ISSN">0364-216X</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term>
<term>Adult</term>
<term>Aged</term>
<term>Blepharoplasty</term>
<term>Drug Combinations</term>
<term>Escin (administration & dosage)</term>
<term>Ethamsylate (administration & dosage)</term>
<term>Hemostatics (administration & dosage)</term>
<term>Humans</term>
<term>Hydrolases (administration & dosage)</term>
<term>Middle Aged</term>
<term>Postoperative Care</term>
<term>Postoperative Complications (prevention & control)</term>
<term>Prospective Studies</term>
<term>Rutin (administration & dosage)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie orale</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Aescine (administration et posologie)</term>
<term>Association médicamenteuse</term>
<term>Blépharoplastie</term>
<term>Complications postopératoires ()</term>
<term>Humains</term>
<term>Hydrolases (administration et posologie)</term>
<term>Hémostatiques (administration et posologie)</term>
<term>Rutoside (administration et posologie)</term>
<term>Soins postopératoires</term>
<term>Sujet âgé</term>
<term>Étamsylate (administration et posologie)</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Escin</term>
<term>Ethamsylate</term>
<term>Hemostatics</term>
<term>Hydrolases</term>
<term>Rutin</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Drug Combinations</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Aescine</term>
<term>Hydrolases</term>
<term>Hémostatiques</term>
<term>Rutoside</term>
<term>Étamsylate</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term>
<term>Adult</term>
<term>Aged</term>
<term>Blepharoplasty</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Postoperative Care</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Administration par voie orale</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association médicamenteuse</term>
<term>Blépharoplastie</term>
<term>Complications postopératoires</term>
<term>Humains</term>
<term>Soins postopératoires</term>
<term>Sujet âgé</term>
<term>Études prospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Increasing demand for shortening the sequel period after aesthetic surgery has led to comparative testing of optional approaches. Systemic enzyme therapy with its pharmacological effects represents a preventive and curative option for inflammatory process including healing. Excellent results were presented, namely, in the treatment of secondary lymphoedema. The incidence of hematoma, edema, and pain was followed, and the results were compared in a randomized group of 20 patients with upper eyelid blepharoplasty treated with proteases (Wobenzym drg) and in a similar group treated with systemic antiedema and hemostyptic therapy (Dicynone drg and Reparil drg). No undesirable side effects were observed. In addition, proteases apparently have no limitation for patients with the risk of concurrent cardiovascular, hepatic, or renal diseases.</div>
</front>
</TEI>
<affiliations><list><country><li>République tchèque</li>
</country>
<region><li>Bohême centrale</li>
</region>
<settlement><li>Prague</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Wald, M" sort="Wald, M" uniqKey="Wald M" first="M" last="Wald">M. Wald</name>
</noCountry>
<country name="République tchèque"><region name="Bohême centrale"><name sortKey="Duskova, M" sort="Duskova, M" uniqKey="Duskova M" first="M" last="Dusková">M. Dusková</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 012A98 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 012A98 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:10022937 |texte= Orally administered proteases in aesthetic surgery. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:10022937" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |